血浆扩张器市场 - 全球产业规模、份额、趋势、机会和预测，按产品类型、最终用户、地区和竞争细分，2020-2030 年预测

2024 年全球血浆扩张器市场价值为 73.2 亿美元，预计到 2030 年将成长到 150.3 亿美元，复合年增长率为 12.71%。由于医疗保健对于创伤、手术、烧伤和休克等危急情况下的容量替代的需求不断增加，该市场有望大幅扩张。血浆扩充剂是重要的静脉注射液，有助于恢復血液量，对于治疗严重脱水和失血至关重要。此外，心臟衰竭、肝病和肾臟病等慢性病的发生率不断上升，进一步加速了对这些产品的需求，因为它们在管理体液平衡和维持重症患者的心血管健康方面发挥着至关重要的作用。手术和密集医疗程序的频率不断增加也推动了市场的成长。

有几个因素推动了等离子扩张器市场的快速发展。羟乙基淀粉 (HES) 和其他合成胶体等合成血浆扩容剂的日益普及，由于其与人类血白蛋白相比的有效性和成本效益，正在推动增长。血浆扩充剂製造和配方技术的进步正在提高其安全性和有效性，增强医疗保健提供者的可及性和可靠性。全球向先进医疗技术的转变和对重症监护管理的高度重视也鼓励了对血浆扩容剂的投资，这在急救和重症监护环境中至关重要。对更安全、更有效的治疗方案的需求推动了该领域的创新，新配方解决了与副作用和安全性相关的挑战。

然而，市场面临着可能影响其成长的若干挑战。一个主要问题是某些合成血浆扩容剂的潜在副作用，特别是羟乙基淀粉 (HES)，在某些情况下它与肾臟损害有关。与新产品审批和复杂临床试验相关的监管挑战可能会延迟新疗法的推出。血浆衍生产品的高成本限制了其在资源匮乏地区的可及性，而对人血白蛋白等人类衍生产品的依赖则引发了对供应短缺、道德考量和病原体传播风险的担忧。为了应对这些挑战，市场必须专注于开发更安全、更有效的替代品，同时提高可近性，以满足全球对血浆扩张剂治疗日益增长的需求。

主要市场驱动因素

技术进步：

主要市场挑战

成本控制：

主要市场趋势

转而使用血浆扩容剂而非输血：

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球血浆扩容剂市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（葡聚醣、羟乙基淀粉、人类血液白蛋白、聚乙二醇化白蛋白、聚乙烯吡咯烷酮 (PVP)、明胶）
  • 按最终用户（网路药局、零售药局、医院药局）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：亚太血浆扩容机市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 7 章：欧洲血浆扩容机市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 8 章：北美血浆扩容机市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第 9 章：南美洲血浆扩张器市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲血浆扩张器市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 13 章：全球血浆扩容剂市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章： 大环境分析

第 16 章：竞争格局

• Baxter International Inc
• Fresenius SE & Co. KGaA
• CSL Limited
• Grifols, SA
• B. Braun Melsungen AG
• Hikma Pharmaceuticals PLC
• Octapharma AG
• Kedrion SpA
• Shanghai RAAS Blood Products Co., Ltd.
• Terumo Corporation

第 17 章：策略建议

第18章 调査会社について・免责事项

The Global Plasma Expander Market was valued at USD 7.32 billion in 2024 and is projected to grow to USD 15.03 billion by 2030, with a CAGR of 12.71%. This market is poised for significant expansion, driven by increasing healthcare demands for volume replacement in critical conditions such as trauma, surgery, burns, and shock. Plasma expanders, vital intravenous solutions, help to restore blood volume and are essential in treating severe dehydration and blood loss. Additionally, the rising prevalence of chronic conditions like heart failure, liver disease, and kidney disorders is further accelerating the demand for these products, as they play a crucial role in managing fluid balance and maintaining cardiovascular health for critically ill patients. The growing frequency of surgeries and intensive medical procedures is also fueling market growth.

Several factors are contributing to the rapid progress of the plasma expander market. The increasing adoption of synthetic plasma expanders, such as Hydroxyethyl Starch (HES) and other synthetic colloids, is driving growth due to their effectiveness and cost-efficiency compared to human albumin. Technological advancements in plasma expander manufacturing and formulation are improving their safety and efficacy, enhancing their accessibility and reliability for healthcare providers. The shift toward advanced medical technologies and a heightened focus on critical care management globally is also encouraging investments in plasma expanders, which are crucial in emergency and intensive care settings. Demand for safer and more effective treatment options is prompting innovation in this field, with new formulations addressing challenges related to side effects and safety profiles.

However, the market faces several challenges that may affect its growth. A key concern is the potential side effects of certain synthetic plasma expanders, particularly Hydroxyethyl Starch (HES), which has been linked to kidney damage in some instances. Regulatory challenges related to the approval of new products and complex clinical trials can delay the introduction of new therapies. The high cost of plasma-derived products limits accessibility in low-resource settings, and reliance on human-derived products, such as human albumin, raises concerns about supply shortages, ethical considerations, and the risk of pathogen transmission. To address these challenges, the market must focus on developing safer and more effective alternatives while improving accessibility to meet the growing demand for plasma expander treatments globally.

Key Market Drivers

Technological Advancements:

Researchers are actively working on developing new formulations of plasma expanders to improve volume-expanding properties while reducing side effects like coagulation disturbances and kidney injury. Advances are also being made in the creation of synthetic plasma expanders that do not rely on human or animal plasma, reducing the risk of infections and immunological reactions. The development of biodegradable plasma expanders, which break down naturally in the body over time, is also underway. Additionally, nanotechnology is being used to enhance the properties of plasma expanders by improving drug delivery, circulation time, and tissue targeting. Technological innovations have led to improved safety profiles, longer shelf life, and more accurate real-time monitoring of patient responses to plasma expanders. In India, for example, the Department of Science and Technology (DST) and the Central Institute of Petrochemicals Engineering & Technology (CIPET) have been pivotal in promoting research and development in this area, further contributing to the advancement of plasma expanders.

Key Market Challenges

Cost Containment:

Healthcare systems globally face budget constraints, leading to cost-containment measures that may impact the purchasing of plasma expanders. The plasma expander market is highly competitive, with multiple manufacturers offering a range of products, which may result in price pressure and reduced profit margins. Additionally, reimbursement policies from government and private insurers can impact the financial viability of plasma expander products, and economic downturns can shift preferences toward cost-effective alternatives. The high costs associated with research, development, and regulatory compliance also complicate the market dynamics, requiring manufacturers to balance affordability with profitability. Efficient supply chain management is essential for reducing costs related to production, distribution, and storage.

Key Market Trends

Shift Toward Plasma Expanders Over Blood Transfusions:

The preference for plasma expanders over blood transfusions is a major driver for market growth. While blood transfusions have traditionally been used to treat significant blood loss, they carry risks such as immunological reactions, infections, blood type mismatches, and allergic responses. Plasma expanders, by mimicking human plasma, offer a safer alternative as they do not carry the same risks of transfusion reactions and infections. They are easier to store, have a longer shelf life, and are more cost-effective than blood transfusions, which involve high costs for blood collection, screening, and storage. As healthcare systems focus on improving trauma care efficiency, plasma expanders are increasingly becoming the preferred method for volume restoration in critical patients, particularly in emergency settings and remote areas with limited access to blood banks.

Key Market Players

• Baxter International Inc.
• Fresenius SE & Co. KGaA
• CSL Limited
• Grifols, S.A.
• B. Braun Melsungen AG
• Hikma Pharmaceuticals PLC
• Octapharma AG
• Kedrion S.p.A.
• Shanghai RAAS Blood Products Co., Ltd.
• Terumo Corporation

Report Scope:

This report segments the Global Plasma Expander Market by product type, end-user, and region, highlighting industry trends and market dynamics.

Product Type Segmentation:

• Dextran
• Hydroxyethyl Starch
• Human Albumin
• PEGylated Albumin
• Polyvinylpyrrolidone (PVP)
• Gelatin

End-User Segmentation:

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

Regional Segmentation:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East & Africa

Competitive Landscape:

Detailed profiles of key market players are included in the report.

Available Customizations:

TechSci Research offers customization options for the Global Plasma Expander Market report, including additional market player analysis and other specific insights tailored to company needs.

Additional company analysis and profiling (up to five additional market players).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plasma Expander Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Dextran, Hydroxyethyl Starch, Human Albumin, PEGylated Albumin, Polyvinylpyrrolidone (PVP), Gelatin)
  • 5.2.2. By End User (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Plasma Expander Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Plasma Expander Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End User
  • 6.3.2. India Plasma Expander Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Australia Plasma Expander Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Japan Plasma Expander Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By End User
  • 6.3.5. South Korea Plasma Expander Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By End User

7. Europe Plasma Expander Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Plasma Expander Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany Plasma Expander Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Spain Plasma Expander Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Plasma Expander Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End User
  • 7.3.5. United Kingdom Plasma Expander Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End User

8. North America Plasma Expander Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Plasma Expander Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Mexico Plasma Expander Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Canada Plasma Expander Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End User

9. South America Plasma Expander Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Plasma Expander Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Plasma Expander Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Plasma Expander Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Plasma Expander Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Plasma Expander Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Plasma Expander Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Plasma Expander Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Plasma Expander Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Baxter International Inc
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Fresenius SE & Co. KGaA
• 16.3. CSL Limited
• 16.4. Grifols, S.A.
• 16.5. B. Braun Melsungen AG
• 16.6. Hikma Pharmaceuticals PLC
• 16.7. Octapharma AG
• 16.8. Kedrion S.p.A.
• 16.9. Shanghai RAAS Blood Products Co., Ltd.
• 16.10.Terumo Corporation

17. Strategic Recommendations

18. About Us & Disclaimer